Honeywell (HON)
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-10-29
$218.33-1.72%
Close 2026-10-30 · 1-day change
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-10-29
Research Workspace
Put HON beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrial Conglomerates is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Sustain free cash flow growth of 4%-10% in 2026: Free cash flow guidance: $2B to $2B.
View ThesisRevenue is contracting — down about 15% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 19%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskHoneywell’s case rests on steady financial performance and sustaining organic revenue growth amid portfolio changes. Q3 revenue grew 1% year over year, and adjusted EPS beat estimates by 4.6%. HON trades at 16× P/E versus a 23× peer median. The market prices in more growth than our forecast, despite weak recent financial standing. The broken free-cash-flow growth pillar and fragile cash backing threaten the case. Our model puts the next-quarter miss probability at 19%. Peer multiples imply a price about 7% below where it trades; the thesis has broken. This read is provisional.
Trailing returns as of 2026-10-30. HON is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering HON (as of Oct 2026).
Based on 9 Wall Street analysts offering 12-month price targets for HON in the last 4 months.
Continue this research
Compare HON with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HON Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Industrial Conglomerates — fair value, gap to price, and forward P/E.
Compare the value case
Put HON next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow sales through organic growth and automation demand
Management expects India revenue to exceed $1 billion, supporting growth and automation demand.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $218.33
The last 12 months of price, then the range of analyst 12-month targets from today’s $218.33.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Grow sales through organic growth and automation demand
AI refinery deployment demonstrates automation demand and supports Honeywell's organic growth objective.
Advances: Maintain and grow revenue with 3%-4% organic growth in 2026
Forecast organic growth exceeds the 3%-4% objective; $2.1B FCF also supports objective 3.
Advances: Achieve adjusted EPS growth of 6%-9% in 2026
Reported 34% EPS growth and guidance raise support the 2026 adjusted EPS growth objective.
Raised annual outlook alongside a Q3 profit beat, supporting confidence in near-term performance.
Threatens: Complete spin-off of Aerospace Technologies by Q3 2026
Exit from spin-off may hinder Aerospace Technologies completion.
Advances: Optimize portfolio with divestitures and acquisitions
AI platform enhances portfolio optimization and growth potential.
Advances: Maintain and grow revenue with 3%-4% organic growth in 2026
New contract supports revenue growth objective.
